Approval · Notice of Compliance 4042 · 1997
BAYRAB: Notice of Compliance 4042
Issued February 12, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4042
- Date
- February 12, 1997
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Passive immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BAYRAB | 02230700 | Cancelled Post Market |
Medicinal ingredients
- RABIES IMMUNOGLOBULIN, HUMAN 150 UNIT per ML